🔎 Trials Near Me

Home › Migraine › NCT07454798

A Feasibility Trial of Virtual Reality Neurofeedback for Adolescents With Migraine

Recruiting

Feasibility of Home-based Immersive Neurofeedback Self-regulation Training (INSeRT) for Youth With Migraine

Who can join

Ages 10 to 16 · All sexes

Full eligibility criteria
Inclusion Criteria:

* Age 10-16 years (inclusive)
* Diagnosis of migraine (with or without aura, or chronic migraine) by a qualified headache specialist
* At least 4 migraine headaches per month
* Presence of headache-free periods between migraine episodes

Exclusion Criteria:

* Significant physical, psychiatric, or developmental conditions that would limit ability to participate in study procedures
* Clinically elevated Pediatric Vestibular Symptoms Questionnaire (PVSQ) score (\>0.68) or new/worsening vestibular symptoms prior to randomization
* Initiation of a new migraine preventive medication within 4 weeks prior to randomization
* Current participation in behavioral treatment for migraine (e.g., cognitive behavioral therapy or biofeedback)
* History of epilepsy or photosensitive seizures

About the study

The goal of this clinical trial is to learn whether a home-based virtual reality (VR) neurofeedback program is feasible and acceptable for adolescents with migraine. The study will also explore whether the program may improve headache-related outcomes.

The main questions it aims to answer are:

Is it feasible to enroll, randomize, and retain adolescents with migraine in this study?

Do participants complete the VR sessions and study procedures as intended?

Are there preliminary signals that the VR neurofeedback program may improve headache-related disability and symptoms?

Researchers will compare Immersive Neurofeedback Self-Regulation Training (INSeRT), which uses brain activity recorded from a wearable electroencephalogram (EEG) headband to guide the VR experience, to a comparison VR program that presents immersive imagery without neurofeedback or guided relaxation training.

Participants will:

Complete a 4-week baseline period that includes headache logs, questionnaires, and a laboratory EEG assessment

Be randomly assigned to one of two VR programs

Complete VR sessions at home three times per week for 4 weeks

Complete questionnaires at the end of treatment and again approximately 3 months later

Repeat the laboratory EEG assessment at the end of treatment

What is being tested

Sponsor: Children's Mercy Hospital Kansas City · Participants: 38 · Started: May 13, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07454798

Locations in the U.S.

MissouriChildren's Mercy, Kansas City

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.